Effects of maxacalcitol ointment on skin lesions in patients with psoriasis receiving treatment with adalimumab

An Evidence-Based Review of the Mechanism of Action, Efficacy, and Safety of Biologic Therapies in the Treatment of Psoriasis and Psoriatic Arthritis

(2015) Elizabeth Brezinski et al.   CURRENT MEDICINAL CHEMISTRY

Adalimumab treatment optimization for psoriasis: Results of a long-term phase 2/3 Japanese study

(2015) Akihiko Asahina et al.   JOURNAL OF DERMATOLOGY

Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort

(2014) M.J. van Geel et al.   BRITISH JOURNAL OF DERMATOLOGY

Japanese guidance for use of biologics for psoriasis (the 2013 version)

(2013) Mamitaro Ohtsuki et al.   JOURNAL OF DERMATOLOGY

Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study

(2011) Gino A. Vena et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Clinical usefulness of a supplementary cyclosporin administration with a topical application of maxacalcitol ointment for patients with moderate psoriasis vulgaris

(2009) Masatoshi ABE et al.   JOURNAL OF DERMATOLOGY